Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography
The use of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for response assessment in lymphoma is now widespread. Prognostic information obtained from PET performed after two to three cycles of chemotherapy may guide more individualized, risk-adapted therapeutic strategies. Progress in...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2011-01-01
|
| Col·lecció: | Advances in Hematology |
| Accés en línia: | http://dx.doi.org/10.1155/2011/271595 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
